Pavel Bárta (Pavel Barta)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 15

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Molecules (Basel, Switzerland)

Journal of labelled compounds & radiopharmaceuticals

Charles University, Faculty of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Charles University, Faculty of Pharmacy Oct 01 2007 - Sep 18 2012

Czechia

PHD :: Pharmacology and Toxicology

Publications

Petr Šlechta, Adam Anthony Needle, Ondřej Janďourek, Pavla Paterová, Klára Konečná, Pavel Bárta, Jiří Kuneš, Vladimír Kubíček, Martin Doležal, Marta Kučerová-Chlupáčová
Design, Synthesis and Antimicrobial Evaluation of New N -(1-Hydroxy-1,3-dihydrobenzo[ c ][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase. International journal of molecular sciences 24 (3) (2023)
Petr Šlechta, Adam Anthony Needle, Ondřej Janďourek, Pavla Paterová, Klára Konečná, Pavel Bárta, Jiří Kuneš, Vladimír Kubíček, Martin Doležal, Marta Kučerová-Chlupáčová
Design, Synthesis and Antimicrobial Evaluation of New N -(1-Hydroxy-1,3-dihydrobenzo[ c ][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase. International journal of molecular sciences 24 (3) (2023)
Petr Šlechta, Adam Anthony Needle, Ondřej Janďourek, Pavla Paterová, Klára Konečná, Pavel Bárta, Jiří Kuneš, Vladimír Kubíček, Martin Doležal, Marta Kučerová-Chlupáčová
Design, Synthesis and Antimicrobial Evaluation of New N -(1-Hydroxy-1,3-dihydrobenzo[ c ][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase. International journal of molecular sciences 24 (3) (2023)
Pavel Bárta, Petr Nachtigal, Jana Maixnerova, Lenka Zemankova, Frantisek Trejtnar
Validation of Freshly Isolated Rat Renal Cells as a Tool for Preclinical Assessment of Radiolabeled Receptor-Specific Peptide Uptake in the Kidney. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
Petr Šlechta, Adam Anthony Needle, Ondřej Janďourek, Pavla Paterová, Klára Konečná, Pavel Bárta, Jiří Kuneš, Vladimír Kubíček, Martin Doležal, Marta Kučerová-Chlupáčová
Design, Synthesis and Antimicrobial Evaluation of New N -(1-Hydroxy-1,3-dihydrobenzo[ c ][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase. International journal of molecular sciences 24 (3) (2023)
Martin Juhás, Andrea Bachtíková, Daria Elżbieta Nawrot, Paulína Dudášová-Hatoková, Vinod Sukanth Kumar Pallabothula, Adéla Diepoltová, Ondřej Janďourek, Pavel Bárta, Klára Konečná, Pavla Paterová, Vít Šesták, Fotios Tsopelas
Correction: Juhás et al. Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole. Pharmaceuticals 2022, 15 , 580. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Martin Juhás, Andrea Bachtíková, Daria Elżbieta Nawrot, Paulína Dudášová-Hatoková, Vinod Sukanth Kumar Pallabothula, Adéla Diepoltová, Ondřej Janďourek, Pavel Bárta, Klára Konečná, Pavla Paterová, Vít Šesták, Fotios Tsopelas
Correction: Juhás et al. Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole. Pharmaceuticals 2022, 15 , 580. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Pavel Bárta, Rajamanikkam Kamaraj, Monika Kucharova, Zbynek Novy, Milos Petrik, Katerina Bendova, Marian Hajduch, Petr Pavek, Frantisek Trejtnar
Preparation, In Vitro Affinity, and In Vivo Biodistribution of Receptor-Specific 68 Ga-Labeled Peptides Targeting Vascular Endothelial Growth Factor Receptors. Bioconjugate chemistry 33 (10) (2022)
Vinod Sukanth Kumar Pallabothula, Marek Kerda, Martin Juhás, Ondřej Janďourek, Klára Konečná, Pavel Bárta, Pavla Paterová, Fotios Tsopelas
Adenosine-Mimicking Derivatives of 3-Aminopyrazine-2-Carboxamide: Towards Inhibitors of Prolyl-tRNA Synthetase with Antimycobacterial Activity. Biomolecules 12 (11) (2022)
Martin Juhás, Andrea Bachtíková, Daria Elżbieta Nawrot, Paulína Dudášová-Hatoková, Vinod Sukanth Kumar Pallabothula, Adéla Diepoltová, Ondřej Janďourek, Pavel Bárta, Klára Konečná, Pavla Paterová, Vít Šesták, Fotios Tsopelas
Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Ghada Bouz, Sarah Bouz, Ondřej Janďourek, Klára Konečná, Pavel Bárta, Jarmila Vinšová, Martin Doležal, Fotios Tsopelas
Synthesis, Biological Evaluation, and In Silico Modeling of N-Substituted Quinoxaline-2-Carboxamides. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Zbynek Novy, Jiri Janousek, Pavel Bárta, Milos Petrik, Marian Hajduch, Frantisek Trejtnar
Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging. Journal of labelled compounds & radiopharmaceuticals 64 (7) (2021)
Martin Juhás, Lucie Kučerová, Ondřej Horáček, Ondřej Janďourek, Vladimír Kubíček, Klára Konečná, Radim Kučera, Pavel Bárta, Jiří Janoušek, Pavla Paterová, Jiří Kuneš, Martin Doležal, Fotios Tsopelas
N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents-The Synthesis and Biological Evaluation of Enantiomers. Molecules (Basel, Switzerland) 25 (7) (2020)
Daria Elżbieta Nawrot, Eliška Suchánková, Ondřej Janďourek, Klára Konečná, Pavel Bárta, Martin Doležal, Fotios Tsopelas
N-pyridinylbenzamides: an isosteric approach towards new antimycobacterial compounds. Chemical biology & drug design 97 (3) (2020)
Weronika Ambrożkiewicz, Marta Kučerová-Chlupáčová, Ondřej Janďourek, Klára Konečná, Pavla Paterová, Pavel Bárta, Jarmila Vinšová, Martin Doležal, Fotios Tsopelas
5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation. Molecules (Basel, Switzerland) 25 (7) (2020)

Pavel Bárta.css-eqlu8i{font-size:small;padding-left:4px;} (Pavel Barta)

Publication Activity (10 Years)

Top Topics

Top Venues

Pavel Bárta (Pavel Barta)